251 related articles for article (PubMed ID: 14716294)
21. Unique and overlapping functions of pRb and p107 in the control of proliferation and differentiation in epidermis.
Ruiz S; Santos M; Segrelles C; Leis H; Jorcano JL; Berns A; Paramio JM; Vooijs M
Development; 2004 Jun; 131(11):2737-48. PubMed ID: 15148303
[TBL] [Abstract][Full Text] [Related]
22. Differential roles of two tandem E2F sites in repression of the human p107 promoter by retinoblastoma and p107 proteins.
Zhu L; Zhu L; Xie E; Chang LS
Mol Cell Biol; 1995 Jul; 15(7):3552-62. PubMed ID: 7791762
[TBL] [Abstract][Full Text] [Related]
23. pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes.
Hurford RK; Cobrinik D; Lee MH; Dyson N
Genes Dev; 1997 Jun; 11(11):1447-63. PubMed ID: 9192872
[TBL] [Abstract][Full Text] [Related]
24. Transcription from the P2 promoter of human protooncogene myc is suppressed by retinoic acid through an interaction between the E2F element and its binding proteins.
Ishida S; Shudo K; Takada S; Koike K
Cell Growth Differ; 1994 Mar; 5(3):287-94. PubMed ID: 8018561
[TBL] [Abstract][Full Text] [Related]
25. Repression of the human immunodeficiency virus type-1 long terminal repeat by the c-Myc oncoprotein.
Stojanova A; Caro C; Jarjour RJ; Oster SK; Penn LZ; Germinario RJ
J Cell Biochem; 2004 May; 92(2):400-13. PubMed ID: 15108364
[TBL] [Abstract][Full Text] [Related]
26. Repression of p15INK4b expression by Myc through association with Miz-1.
Staller P; Peukert K; Kiermaier A; Seoane J; Lukas J; Karsunky H; Möröy T; Bartek J; Massagué J; Hänel F; Eilers M
Nat Cell Biol; 2001 Apr; 3(4):392-9. PubMed ID: 11283613
[TBL] [Abstract][Full Text] [Related]
27. ECA39 is regulated by c-Myc in human and by a Jun/Fos homolog, Gcn4, in yeast.
Ben-Yosef T; Yanuka O; Benvenisty N
Oncogene; 1996 Nov; 13(9):1859-66. PubMed ID: 8934531
[TBL] [Abstract][Full Text] [Related]
28. Expression of the TAF4b gene is induced by MYC through a non-canonical, but not canonical, E-box which contributes to its specific response to MYC.
Teye K; Okamoto K; Tanaka Y; Umata T; Ohnuma M; Moroi M; Kimura H; Tsuneoka M
Int J Oncol; 2008 Dec; 33(6):1271-80. PubMed ID: 19020761
[TBL] [Abstract][Full Text] [Related]
29. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.
Kinney EL; Tanida S; Rodrigue AA; Johnson JK; Tompkins VS; Sakamuro D
J Cell Physiol; 2008 Sep; 216(3):621-31. PubMed ID: 18348166
[TBL] [Abstract][Full Text] [Related]
30. New Myc-interacting proteins: a second Myc network emerges.
Sakamuro D; Prendergast GC
Oncogene; 1999 May; 18(19):2942-54. PubMed ID: 10378691
[TBL] [Abstract][Full Text] [Related]
31. Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter.
Wu S; Cetinkaya C; Munoz-Alonso MJ; von der Lehr N; Bahram F; Beuger V; Eilers M; Leon J; Larsson LG
Oncogene; 2003 Jan; 22(3):351-60. PubMed ID: 12545156
[TBL] [Abstract][Full Text] [Related]
32. PARP-1 binds E2F-1 independently of its DNA binding and catalytic domains, and acts as a novel coactivator of E2F-1-mediated transcription during re-entry of quiescent cells into S phase.
Simbulan-Rosenthal CM; Rosenthal DS; Luo R; Samara R; Espinoza LA; Hassa PO; Hottiger MO; Smulson ME
Oncogene; 2003 Nov; 22(52):8460-71. PubMed ID: 14627987
[TBL] [Abstract][Full Text] [Related]
33. Promoter-binding and repression of PDGFRB by c-Myc are separable activities.
Mao DY; Barsyte-Lovejoy D; Ho CS; Watson JD; Stojanova A; Penn LZ
Nucleic Acids Res; 2004; 32(11):3462-8. PubMed ID: 15226411
[TBL] [Abstract][Full Text] [Related]
34. Dual promoter structure of ZFP106: regulation by myogenin and nuclear respiratory factor-1.
Grasberger H; Ye H; Mashima H; Bell GI
Gene; 2005 Jan; 344():143-59. PubMed ID: 15656981
[TBL] [Abstract][Full Text] [Related]
35. The proximal promoter of the human cathepsin G gene conferring myeloid-specific expression includes C/EBP, c-myb and PU.1 binding sites.
Lennartsson A; Garwicz D; Lindmark A; Gullberg U
Gene; 2005 Aug; 356():193-202. PubMed ID: 16019164
[TBL] [Abstract][Full Text] [Related]
36. The transcriptional repressor gene Mad3 is a novel target for regulation by E2F1.
Fox EJ; Wright SC
Biochem J; 2003 Feb; 370(Pt 1):307-13. PubMed ID: 12444919
[TBL] [Abstract][Full Text] [Related]
37. In vivo regulation of single copy and amplified N-myc in human neuroblastoma cells.
Lutz W; Schwab M
Oncogene; 1997 Jul; 15(3):303-15. PubMed ID: 9233765
[TBL] [Abstract][Full Text] [Related]
38. Three distinct elements within the murine c-myc promoter are required for transcription.
Moberg KH; Logan TJ; Tyndall WA; Hall DJ
Oncogene; 1992 Mar; 7(3):411-21. PubMed ID: 1549358
[TBL] [Abstract][Full Text] [Related]
39. Direct role for Myc in transcription initiation mediated by interactions with TFII-I.
Roy AL; Carruthers C; Gutjahr T; Roeder RG
Nature; 1993 Sep; 365(6444):359-61. PubMed ID: 8377829
[TBL] [Abstract][Full Text] [Related]
40. c-MYC repression of promoter activity through core promoter elements.
Lucas JM; Wilkie NM; Lang JC
Biochem Biophys Res Commun; 1993 Aug; 194(3):1446-52. PubMed ID: 8352803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
